Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
35.20
-0.30 (-0.85%)
At close: Mar 24, 2026, 4:00 PM EDT
35.70
+0.50 (1.42%)
After-hours: Mar 24, 2026, 7:42 PM EDT
Liquidia Revenue
In the year 2025, Liquidia had annual revenue of $158.32M with 1,031.18% growth. Liquidia had revenue of $92.02M in the quarter ending December 31, 2025, with 3,054.65% growth.
Revenue (ttm)
$158.32M
Revenue Growth
+1,031.18%
P/S Ratio
19.59
Revenue / Employee
$732,963
Employees
216
Market Cap
3.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 158.32M | 144.32M | 1,031.18% |
| Dec 31, 2024 | 14.00M | -3.49M | -19.97% |
| Dec 31, 2023 | 17.49M | 1.55M | 9.75% |
| Dec 31, 2022 | 15.94M | 3.08M | 23.98% |
| Dec 31, 2021 | 12.85M | 12.11M | 1,637.77% |
| Dec 31, 2020 | 739.63K | -7.33M | -90.84% |
| Dec 31, 2019 | 8.07M | 5.37M | 198.20% |
| Dec 31, 2018 | 2.71M | -4.55M | -62.70% |
| Dec 31, 2017 | 7.26M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.27B |
| Amneal Pharmaceuticals | 3.02B |
| Hims & Hers Health | 2.35B |
| Lantheus Holdings | 1.54B |
| Alkermes | 1.48B |
| Phibro Animal Health | 1.46B |
| Prestige Consumer Healthcare | 1.10B |
| BioCryst Pharmaceuticals | 874.84M |
LQDA News
- 18 days ago - Liquidia Analysts Boost Their Forecasts After Q4 Earnings - Benzinga
- 19 days ago - Liquidia Corporation (LQDA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 25 days ago - Liquidia Appears Set For Strong 2026 On Further Share Gains - Seeking Alpha
- 26 days ago - Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026 - GlobeNewsWire
- 2 months ago - Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored - Seeking Alpha
- 4 months ago - Liquidia Corporation (LQDA) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha